High prevalence of the metabolic syndrome among Northern Jordanians

被引:58
作者
Khader, Yousef
Bateiha, Anwar
El-Khateeb, Mohammed
Al-Shaikh, Abeer
Ajlouni, Kamel [1 ]
机构
[1] Natl Ctr Diabet, Amman 11942, Jordan
[2] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth & Community Med, Irbid, Jordan
关键词
metabolic syndrome; diabetes; obesity; prevalence; Jordan;
D O I
10.1016/j.jdiacomp.2005.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The prevalence of the metabolic syndrome is rapidly increasing with a considerable ethnic variation within and across populations. This study was conducted to estimate the prevalence of the metabolic syndrome and its individual components using Adult Treatment Panel III (ATP 111) criteria among Northern Jordanians. Methods: Data were analyzed from a cross-sectional study that included a random sample of 1121 northern Jordanians aged 25 years and above. The metabolic syndrome was defined by ATP III criteria. Results: The age-adjusted prevalence of the metabolic syndrome was 36.3% (95% CI 33.6-39.0%) (28.7% among men and 40.9% among women). The prevalence increased significantly with age in men and women. The prevalence of the metabolic syndrome was significantly higher in women than in men in age groups of 40-49 and 60 years and above. Low HDL cholesterol was the most common abnormality in men (62.7%), and abdominal obesity was the most common abnormality in women (69.1 %). Conclusions: Prevalence of the metabolic syndrome in North Jordan is considerably higher than in developed countries and other Arab populations. An integrated approach is needed for the prevention and treatment of the metabolic syndrome. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:214 / 219
页数:6
相关论文
共 29 条
[21]   GLOBAL ESTIMATES FOR PREVALENCE OF DIABETES-MELLITUS AND IMPAIRED GLUCOSE-TOLERANCE IN ADULTS [J].
KING, H ;
REWERS, M .
DIABETES CARE, 1993, 16 (01) :157-177
[22]   The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men [J].
Lakka, HM ;
Laaksonen, DE ;
Lakka, TA ;
Niskanen, LK ;
Kumpusalo, E ;
Tuomilehto, J ;
Salonen, JT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (21) :2709-2716
[23]   Development of the multiple metabolic syndrome: An epidemiologic perspective [J].
Liese, AD ;
Mayer-Davis, EJ ;
Haffner, SM .
EPIDEMIOLOGIC REVIEWS, 1998, 20 (02) :157-172
[24]   Role of fibrates in reducing coronary risk: a UK consensus [J].
Mikhailidis, DP .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (02) :241-247
[25]  
Ozsahin AK, 2004, DIABETES NUTR METAB, V17, P230
[26]   The metabolic syndrome - Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 [J].
Park, YW ;
Zhu, SK ;
Palaniappan, L ;
Heshka, S ;
Carnethon, MR ;
Heymsfield, SB .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (04) :427-436
[27]   Metabolic syndrome in urban Asian Indian adults - a population study using modified ATP III criteria [J].
Ramachandran, A ;
Snehalatha, C ;
Satyavani, K ;
Sivasankari, S ;
Vijay, V .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 60 (03) :199-204
[28]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[29]  
Segi M., 1960, CANC MORTALITY SELEC